Chronic Kidney Disease Trial, Recruiting NCT06576479 Sponsor: NIN Institute Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT06576479
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have diabetic kidney disease with reduced kidney function at a specific level (known as stage G3a, G3b, or G4 — confirm exact level with trial site)
  • People whose blood protein levels (albumin) are below a certain threshold, which can be a sign that the body is not getting enough protein and energy from food
  • People whose diet records show they are eating very little protein or calories per day
  • People who are able to read and write, or who have a primary caregiver who can do so
  • People who live within the metropolitan area where the trial is based

Who may not be able to join:

  • People who have been hospitalised in the month before the trial
  • People who have serious health conditions such as a chronic infection, blood infection (septicemia), cancer, HIV, Alzheimer's disease, uncontrolled heart failure, liver failure, stroke-related conditions, a condition affecting how the body absorbs food, or a known allergy to any ingredient in the nutritional supplement being studied
  • People who are currently taking nutritional supplements or a type of supplement called keto analogues

People already in the trial may be withdrawn if:

  • They miss their nutrition and blood test check-ups at the required time points (the start, two months in, and the end of the study)
  • They miss more than 10% of their required supplement doses (more than 12 doses)
  • A new health condition is diagnosed during the trial period
  • They begin kidney replacement therapy (such as dialysis) during the trial
  • They experience unwanted side effects
  • They choose to withdraw from the trial voluntarily
  • They pass away during the study period

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paola Azucena Alvarado Pelayo, Bachelor, Hospital Civil Fray Antonio Alcalde

Phone: 011 52 3320587471

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
NIN Institute
Registry
ClinicalTrials.gov
Start date
10 July 2018
Est. completion
1 February 2025

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Serum Albumin (g/dl); Dietary intake (kcal/kg/day)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov